Anondita Medicare September-Half Profit Rises to Rs 22.01 Crore
Key highlights
- Anondita Medicare reported September 2026 half-year consolidated profit after tax of Rs 22.01 crore, compared with Rs 13.02 crore a year earlier.
- Anondita Medicare’s revenue from operations rose to Rs 73.54 crore from Rs 54.10 crore in the September 2025 half.
- Anondita Medicare’s profit before tax increased to Rs 29.45 crore from Rs 17.38 crore year on year.
- Anondita Medicare reported total assets of Rs 351.79 crore at September 30, 2026, compared with Rs 184.83 crore at March 31, 2026.
powered by IRIS

Anondita Medicare Limited reported consolidated profit after tax of Rs 22.01 crore for the half year ended September 30, 2026, compared with Rs 13.01 crore a year earlier, as revenue from operations increased to Rs 73.54 crore from Rs 54.10 crore.
Know Anondita Medicare inside out
Results, valuation, peers and who's buying, in one view.
How did Anondita Medicare’s September-half earnings change?
Anondita Medicare’s consolidated profit after tax increased by Rs 8.99 crore year on year to Rs 22.01 crore in the half year ended September 30, 2026. Profit before tax rose to Rs 29.45 crore from Rs 17.38 crore in the half year ended September 30, 2025, while the statement showed no exceptional or extraordinary items in either period.
Profit after tax was also above the Rs 21.28 crore reported in the half year ended March 31, 2026, although profit before tax was marginally below Rs 29.51 crore in that preceding half. The difference between the pre-tax and post-tax results reflects current tax of Rs 7.00 crore and deferred-tax expense of Rs 44.93 lakh in the September 2026 half.
Anondita Medicare attributed Rs 21.31 crore of the September 2026 half-year profit to owners of the company and Rs 69.78 lakh to minority interest. In the corresponding prior-year half, profit attributable to owners was Rs 12.86 crore and minority interest was Rs 16.23 lakh; basic and diluted earnings per equity share were Rs 11.76 in September 2026, against Rs 9.08 a year earlier.
What happened to Anondita Medicare’s revenue in September 2026?
Anondita Medicare’s revenue from operations rose to Rs 73.54 crore in the September 2026 half from Rs 54.10 crore in the September 2025 half. Other income was Rs 60.48 lakh, compared with Rs 40.78 lakh a year earlier, taking total income to Rs 74.15 crore from Rs 54.50 crore.
The year-on-year rise in total income was Rs 19.65 crore, while profit before tax increased by Rs 12.08 crore. Revenue from operations was nevertheless Rs 9.78 crore lower than the Rs 83.32 crore reported in the half year ended March 31, 2026, when other income was Rs 43.46 lakh and total income was Rs 83.75 crore.
For the year ended March 31, 2026, Anondita Medicare reported revenue from operations of Rs 137.42 crore and profit after tax of Rs 34.30 crore. The September 2026 half-year revenue therefore represented more than half of the preceding full-year revenue, but the filing does not provide management guidance or a target for the remaining half of the financial year.
Which Anondita Medicare expenses changed during the half year?
Anondita Medicare reported total expenses of Rs 44.69 crore for the half year ended September 30, 2026, up from Rs 37.13 crore in the prior-year half. Cost of materials consumed increased to Rs 27.75 crore from Rs 23.53 crore, and purchases of stock-in-trade increased to Rs 12.95 crore from Rs 1.65 crore.
The change in inventories of finished goods, work in progress and stock-in-trade was negative Rs 12.78 crore in September 2026, compared with negative Rs 79.18 lakh a year earlier. Employee benefit expense rose to Rs 4.61 crore from Rs 3.48 crore, while finance costs increased to Rs 2.42 crore from Rs 1.82 crore.
Depreciation and amortisation expense was Rs 1.42 crore in the September 2026 half, compared with Rs 40.87 lakh in the September 2025 half. Other expenses rose to Rs 8.30 crore from Rs 7.02 crore. Against the immediately preceding March 2026 half, total expenses declined from Rs 54.24 crore to Rs 44.69 crore as total income declined from Rs 83.75 crore to Rs 74.15 crore.
Got a follow-up? Ask IRIS
What does Anondita Medicare’s September 2026 balance sheet show?
Anondita Medicare reported consolidated total assets of Rs 351.79 crore at September 30, 2026, compared with Rs 184.83 crore at March 31, 2026. Cash and cash equivalents increased to Rs 91.51 crore from Rs 9.65 crore, while trade receivables rose to Rs 60.02 crore from Rs 51.86 crore.
Inventories stood at Rs 35.17 crore at September 30, 2026, compared with Rs 20.75 crore at the March 2026 year-end. Property, plant and equipment rose to Rs 52.97 crore from Rs 39.10 crore, and capital work in progress increased to Rs 74.21 crore from Rs 41.50 crore.
Long-term borrowings were Rs 42.73 crore at September 30, 2026, up from Rs 23.87 crore at March 31, while short-term borrowings increased to Rs 27.88 crore from Rs 9.73 crore. Share capital was Rs 19.04 crore, reserves and surplus were Rs 221.02 crore, and the balance sheet included Rs 7.40 crore received against share warrants.
What did the limited review say about Anondita Medicare’s results?
Jain Chopra & Company issued an unmodified limited-review conclusion on Anondita Medicare’s unaudited consolidated financial results on November 14, 2026. The auditor said that nothing had come to its attention that caused it to believe the statement did not disclose the required information or contained a material misstatement.
The review was conducted under Standard on Review Engagements 2410, which the report describes as substantially narrower in scope than an audit. The consolidated statement covers Anondita Medicare, subsidiary Anondita Pharma and Latex Limited, formerly Anondita Healthcare and Rubber Products India Limited, and associate Anondita Healthcare, a partnership firm.
The auditor noted that the group’s share of net profit after tax associated with the subsidiary was Rs 6.33 crore for the half year ended September 30, 2026, compared with Rs 1.48 crore in the September 2025 half. That interim financial statement was reviewed by another auditor, and Jain Chopra & Company based its conclusion on that report and its own procedures.
Conclusion
Anondita Medicare’s September 2026 half-year results show a year-on-year increase in both revenue and earnings. Revenue from operations rose by Rs 19.44 crore to Rs 73.54 crore, while profit after tax increased by Rs 8.99 crore to Rs 22.01 crore despite higher materials, stock-in-trade, employee, finance and depreciation costs.
The next results will show how the September-half profit compares with the Rs 21.28 crore earned in the March 2026 half and whether balance-sheet changes continue. Items to monitor include Rs 74.21 crore of capital work in progress, Rs 42.73 crore of long-term borrowings and Rs 27.88 crore of short-term borrowings reported at September 30, 2026.


